Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma
Condition(s):Brain and Central Nervous System TumorsLast Updated:August 21, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Brain and Central Nervous System TumorsLast Updated:August 21, 2018Completed
Condition(s):Metastatic Pancreatic CancerLast Updated:December 9, 2016Completed
Condition(s):CNS Tumor, AdultLast Updated:April 20, 2016Completed
Condition(s):Newly Diagnosed Pediatric Pontine Glioma; Newly Diagnosed Pediatric High Grade Glioma; Recurrent Pediatric High Grade Glioma; Recurrent Pediatric Low Grade GliomaLast Updated:November 3, 2023Active, not recruiting
Condition(s):Breast CancerLast Updated:May 8, 2020Terminated
Condition(s):Non Small Cell Lung Cancer; Advanced Triple Negative Breast Cancer; Small Cell Lung Cancer; Urothelial Cancer; Mesothelioma; Malignant MelanomaLast Updated:December 7, 2016Withdrawn
Condition(s):Influenza; Severe Acute Respiratory Distress Syndrome; Smallpox; Ebola; Unknown Respiratory VirusesLast Updated:July 5, 2018Completed
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:May 7, 2008Unknown status
Condition(s):Brain and Central Nervous System TumorsLast Updated:July 18, 2018Terminated
Condition(s):COVID – 19Last Updated:May 18, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.